Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT
Landec Corporation (Nasdaq: LNDC) announced it will host a conference call on October 5, 2022, at 2:00 PM PT to discuss its fiscal 2023 first quarter financial results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Landec Corporation (Nasdaq: LNDC) announced it will host a conference call on October 5, 2022, at 2:00 PM PT to discuss its fiscal 2023 first quarter financial results. The live webcast will be available for 30 days on Landec's website. Participants can join the call by dialing toll-free numbers for U.S. and international calls. A replay will be accessible until October 12, 2022. As a diversified health and wellness company, Landec's Lifecore Biomedical business specializes in contract development and manufacturing of sterile injectable pharmaceutical products.
Positive
- Scheduled conference call for fiscal 2023 Q1 financial results indicates transparency and engagement with investors.
- Lifecore Biomedical's expertise in sterile injectable products highlights growth potential in the pharmaceutical sector.
Negative
- None.
Details
News Market Reaction – LNDC
The recorded move for LNDC in the trading session of this news was -0.16%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that it will host a conference call to discuss fiscal 2023 first quarter financial results. The live webcast can be accessed via Landec’s website on the Investor Events & Presentations page. The webcast will be available for 30 days.
Date: Wednesday, October 5, 2022
Time: 2:00 p.m. Pacific time (5:00 p.m. Eastern time)
Direct Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1571075&tp_key=1996ac9554
To participate in the conference call via telephone, dial toll-free: 1-877-407-3982 (U.S.) or 1-201-493-6780 (International). Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization.
A replay of the call will be available through October 12th, by calling toll-free: 1-844-512-2921 (U.S.) or 1-412-317-6671 (International), and entering code 13732915.
About Landec Corporation
Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with
Landec Corp. Contact Information:
Investor Relations
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.